Retaglutide is a cutting-edge GLP-1 receptor agonist currently under research for the treatment of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://louisefyvg273271.activosblog.com/37666302/retaglutide-a-promising-glp-1-receptor-agonist